Beam Therapeutics Stock Technical Analysis
| BEAM Stock | USD 23.58 0.91 3.72% |
As of the 22nd of November, Beam Therapeutics shows the mean deviation of 3.08, and Risk Adjusted Performance of 0.0233. Beam Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Beam Therapeutics jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Beam Therapeutics is priced correctly, providing market reflects its regular price of 23.58 per share. Given that Beam Therapeutics has jensen alpha of (0.22), we suggest you to validate Beam Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.
Beam Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Beam, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BeamBeam |
Beam Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 67.0 | Buy | 18 | Odds |
Most Beam analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Beam stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Beam Therapeutics, talking to its executives and customers, or listening to Beam conference calls.
Beam Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Beam Therapeutics Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Beam Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Beam Therapeutics Trend Analysis
Use this graph to draw trend lines for Beam Therapeutics. You can use it to identify possible trend reversals for Beam Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Beam Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Beam Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Beam Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0007 , which may suggest that Beam Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.02, which is the sum of squared deviations for the predicted Beam Therapeutics price change compared to its average price change.About Beam Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Beam Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Beam Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Beam Therapeutics price pattern first instead of the macroeconomic environment surrounding Beam Therapeutics. By analyzing Beam Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Beam Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Beam Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.0119 | 0.0106 | Price To Sales Ratio | 5.56 | 5.28 |
Beam Therapeutics November 22, 2024 Technical Indicators
Most technical analysis of Beam help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Beam from various momentum indicators to cycle indicators. When you analyze Beam charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0233 | |||
| Market Risk Adjusted Performance | 0.0317 | |||
| Mean Deviation | 3.08 | |||
| Semi Deviation | 3.59 | |||
| Downside Deviation | 3.66 | |||
| Coefficient Of Variation | 5002.14 | |||
| Standard Deviation | 4.24 | |||
| Variance | 17.94 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0217 | |||
| Maximum Drawdown | 20.75 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 7.79 | |||
| Downside Variance | 13.37 | |||
| Semi Variance | 12.92 | |||
| Expected Short fall | (3.59) | |||
| Skewness | 0.5671 | |||
| Kurtosis | 1.07 |
Beam Therapeutics November 22, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Beam stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 56,419 | ||
| Daily Balance Of Power | (0.66) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 24.02 | ||
| Day Typical Price | 23.87 | ||
| Price Action Indicator | (0.90) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.58) | Revenue Per Share 4.273 | Quarterly Revenue Growth (0.17) | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.